Effects of a diphosphonate (disodium etidronate: EHDP) on phosphate metabolism in Paget's disease of bone, primary hyperparathyroidism and type I hypophosphataemic rickets.

Effects of a diphosphonate (disodium etidronate: EHDP) on phosphate metabolism in Paget's disease of bone, primary hyperparathyroidism and type I hypophosphataemic rickets.

Detalhes bibliográficos
Principais autores:	Walton, R, Smith, R, Russell, R
Formato:	Journal article
Idioma:	English
Publicado em:	Springer-Verlag 1976

Registros relacionados

Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment.
por: Smith, R, et al.
Publicado em: (1973)

Changes in the renal and extrarenal handling of phosphate induced by disodium etidronate (EHDP) in man.
por: Walton, R, et al.
Publicado em: (1975)

Proceedings: Some effects of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on calcium metabolism in man.
por: Walton, R, et al.
Publicado em: (1974)

STUDIES ON HYPERPHOSPHATEMIA INDUCED BY DISODIUM ETHANE-1-HYDROXY-1, 1-DIPHOSPHONATE (EHDP) IN MAN
por: Walton, R, et al.
Publicado em: (1974)

Reduction of skeletal blood flow in Paget's disease with disodium etidronate therapy
por: Walton, K, et al.
Publicado em: (1985)

Diphosphonates in Paget's disease.
por: Russell, R, et al.
Publicado em: (1974)

ABNORMAL RESPONSES TO EHDP TREATMENT OF PAGETS-DISEASE
por: Smith, R, et al.
Publicado em: (1977)

Calcium Phosphate/Etidronate Disodium Biocement: Etidronate, Retarder or Accelerator
por: Nasim Nosoudi, et al.
Publicado em: (2014-03-01)

The effect of 1,25-dihydroxycholecalciferol on renal tubular reabsorption of phosphate, intestinal absorption of calcium and bone histology in hypophosphataemic renal tubular rickets.
por: Russell, R, et al.
Publicado em: (1975)

RESPONSE OF THE BONE AND KIDNEY TO EHDP IN MAN
por: Russell, R, et al.
Publicado em: (1979)

Duration of effect of oral diphosphonate therapy in Paget's disease of bone.
por: Gray, R, et al.
Publicado em: (1987)

Hypophosphatemic rickets developed after treatment with etidronate disodium in a patient with generalized arterial calcification in infancy
por: Kentaro Miyai, et al.
Publicado em: (2015-12-01)

Effective short term treatment of Paget's disease with oral etidronate.
por: Preston, C, et al.
Publicado em: (1986)

Windswept lower limb deformities in patients with hypophosphataemic rickets
por: Ali Al Kaissi, et al.
Publicado em: (2013-12-01)

Bridging markers defining the map position of X linked hypophosphataemic rickets.
por: Thakker, R, et al.
Publicado em: (1987)

Mapping of human X-linked hypophosphataemic rickets by multilocus linkage analysis.
por: Read, A, et al.
Publicado em: (1986)

X-linked hypophosphataemic rickets due to pseudo-exons of the PHEX gene.
por: Christie, P, et al.
Publicado em: (2000)

Genetic basis of hereditary hypophosphataemic rickets and phenotype presentation in children and adults
por: Tavana, Nahid, et al.
Publicado em: (2021)

Genetic linkage studies of X-linked hypophosphataemic rickets in a Saudi Arabian family.
por: Thakker, R, et al.
Publicado em: (1992)

Seven novel mutations in the PEX gene indicate molecular heterogeneity for X-linked hypophosphataemic rickets.
por: Dixon, P, et al.
Publicado em: (1996)

Novel compound heterozygous mutations in ENPP1 cause hypophosphataemic rickets with anterior spinal ligament ossification.
por: Mehta, P, et al.
Publicado em: (2012)

Biochemical measurements in Paget's disease of bone.
por: Walton, R, et al.
Publicado em: (1977)

X-linked hypophosphataemic rickets in a Saudi Arabian kindred results from a nonsense mutation of the PEX gene.
por: Dixon, P, et al.
Publicado em: (1997)

Diphosphonates and polyphosphates in medicine
por: Russell, R
Publicado em: (1975)

Proceedings: Background to the use of diphosphonates as bone scanning agents.
por: Russell, R, et al.
Publicado em: (1975)

Histological measurements in Paget's disease of bone.
por: Walton, R, et al.
Publicado em: (1977)

Hypophosphataemic Rickets Secondary to Raine Syndrome: A Review of the Literature and Case Reports of Three Paediatric Patients’ Dental Management
por: Lorna Hirst, et al.
Publicado em: (2021-01-01)

Treatment of myositis ossificans progressiva with a diphosphonate.
por: Russell, R, et al.
Publicado em: (1972)

Paget’s Disease and Secondary Hyperparathyroidism: Is Healing Possible?
por: Vincenzo Antonio Panuccio, et al.
Publicado em: (2020-05-01)

Frequencies of HLA-A and HLA-B histocompatibility antigens in Paget's disease of bone.
por: Cullen, P, et al.
Publicado em: (1976)

An estimate of the turnover rate of bone-derived plasma alkaline phosphatase in Paget's disease.
por: Walton, R, et al.
Publicado em: (1975)

Pyrophosphate and diphosphonates in skeletal metabolism. Physiological, clinical and therapeutic aspects.
por: Russell, R, et al.
Publicado em: (1975)

De Novo Large Deletions in the <i>PHEX</i> Gene Caused X-Linked Hypophosphataemic Rickets in Two Italian Female Infants Successfully Treated with Burosumab
por: Carmine Pecoraro, et al.
Publicado em: (2023-07-01)

The prevention of corticosteroid-induced bone loss with intermittent cyclical etidronate.
por: Jenkins, E, et al.
Publicado em: (1999)

Primary lymphoma arising in Paget’s disease in a patient with primary hyperparathyroidism
por: Mercedes De La Fuente, et al.
Publicado em: (2025-01-01)

A Rare Case of Hypophosphataemic Osteomalacia in von Recklinghausen Neurofibromatosis
por: Yasmine Makhlouf, et al.
Publicado em: (2021-05-01)

Cyclical etidronate prevents spinal bone loss in early post-menopausal women.
por: Tobias, J, et al.
Publicado em: (1997)

Predicting the impact of PHEX, FGF23 and DMP1 gene variants found in Malaysian Malay patients with Hypophosphataemic Rickets through in silico analysis of protein function and mRNA secondary structure
por: Razali, Nurul Nadirah, et al.
Publicado em: (2019)

Novel use of burosumab in refractory iron-induced FGF23-mediated hypophosphataemic osteomalacia
por: Amarnani, R, et al.
Publicado em: (2020)

Paget's bone disease
por: Fábio Freire José, et al.
Publicado em: (2008-03-01)